Insiders / Kumar Neil

Kumar Neil

CIK 1742485personinsider

Companies

2

First seen

Jan 12, 2026

Last activity

Mar 31, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
BridgeBio Pharma, Inc. · BBIO	CEO	5,308,584	4,546,882	48	—
Maze Therapeutics, Inc. · MAZE	Director	—	33,417	1	—

All securities held

4 positions · latest reported per filing

Company	Security	Shares	As of
BridgeBio Pharma, Inc.	Common Stock	5,308,584	Mar 13, 2026
BridgeBio Pharma, Inc.	Restricted Stock UnitsDerivative	104,313	Mar 17, 2026
BridgeBio Pharma, Inc.	Stock Option (Right to Buy)Derivative	40,570	Mar 17, 2026
Maze Therapeutics, Inc.	Stock Option (Right to Buy)Derivative	33,417	Mar 27, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Feb 16, 2026	Other	BBIO BridgeBio Pharma, Inc. Common Stock	$2.33M	-31K -10.55%	262,504 0.13% of shares	low
Feb 19, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$1.34M	-19K -7.21%	243,581 0.12% of shares	medium
Feb 10, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$1.02M	-14K -1.98%	701,485 0.36% of shares	medium
Feb 10, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$1.01M	-14K -0.31%	4,504,407 2.30% of shares	medium
Mar 12, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$981.8K	-14K -2.12%	661,349 0.34% of shares	medium
Mar 12, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$950.7K	-14K -0.31%	4,464,562 2.28% of shares	medium
Jan 8, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$851.8K	-12K -0.25%	4,546,882 2.33% of shares	medium
Jan 8, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$848.0K	-12K -1.52%	744,171 0.38% of shares	medium
Jan 9, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$827.0K	-11K -0.24%	4,520,302 2.31% of shares	medium
Jan 9, 2026	Sell	BBIO BridgeBio Pharma, Inc. Common Stock	$816.4K	-11K -1.45%	716,061 0.37% of shares	medium